QHU-25216-93960 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-22
Dose 1 — Pfizer-BioNTech
2021-01-13
Dose 2 — Pfizer-BioNTech
2021-12-07
Dose 3 — Pfizer-BioNTech
2021-12-22
Registered in v-safe
2021-12-22
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2021-12-28
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2022-01-04
Survey response — day 28, dose 3
MedDRA: Chills, Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school

Free text: Congestion runny nose chills

MedDRA releases: 2024-11 · check-in free text available
2022-01-11
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2022-01-18
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2022-03-10
Health check-in — 3 months, dose 3
Feeling: Fair

Adult check-in
2022-06-09
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2022-12-10
Health check-in — 12 months, dose 3
Feeling: Fair

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-22	Pfizer-BioNTech	No
2	2021-01-13	Pfizer-BioNTech	No
3	2021-12-07	Pfizer-BioNTech	No

Free text

Release 10 — day 28, dose 3

2022-01-04

Symptoms: Congestion runny nose chills

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Chills	·	·	✓
SD	Respiratory tract congestion	·	·	✓
SD	Rhinorrhoea	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release